KBRA Releases Third-Quarter 2022 U.S. Bank Compendium and 2023 Sector Outlook
11/15/2022 - 06:05 PM
NEW YORK --(BUSINESS WIRE)--
KBRA releases its third-quarter 2022 U.S. Bank Compendium and 2023 Sector Outlook, providing the latest view of the U.S. banking industry, including KBRA’s sector outlook, and analysis of 3Q22 results for U.S. banks with KBRA long-term ratings. In this edition, we discuss the resilience of our rated universe amid the intensified tightening cycle and competing tailwinds and headwinds. Despite an uncertain macro environment, we recognize banks as better positioned to withstand stressed conditions versus previous cycles, with stronger capital profiles, generally reduced asset and liability concentration risk, and higher loss buffers in place—all factors that underpin our Stable Outlook for the U.S. banking industry. The report also examines other key topics and trends relevant to the banking sector. In addition, the Compendium includes our quarterly environmental, social, and governance (ESG) Bulletin, which features Berkshire Hills Bancorp, Inc. (NYSE: BHLB; KBRA Senior BHC Rating: BBB/Stable Outlook).
The Compendium includes 3Q22 summaries on all publicly traded U.S. banks in KBRA’s rated universe, focusing on key performance and credit metrics, along with medians of key ratios. The Compendium also includes the top 10 lowest cost deposit franchises, highest reserves to loans, and largest sequential changes in return on assets, net interest margin, net charge-offs, and nonperforming asset ratios. In addition, we provide a supplement with 170 debt issues—along with rating, amount issued, coupon, and maturity—among KBRA-rated banks.
Click here to view the report.
Related Publications
About KBRA
KBRA is a full-service credit rating agency registered in the U.S. , the EU, and the UK , and is designated to provide structured finance ratings in Canada . KBRA’s ratings can be used by investors for regulatory capital purposes in multiple jurisdictions.
View source version on businesswire.com : https://www.businesswire.com/news/home/20221115006535/en/
Leah Hallfors , Senior Director
+1 (301) 969-3242
leah.hallfors@kbra.com
Brian Ropp , Managing Director
+1 (301) 969-3244
brian.ropp@kbra.com
Bryan So, Director
+1 (301) 969-3246
bryan.so@kbra.com
Shannon Servaes , CFA, CPA Managing Director
+1 (301) 969-3247
shannon.servaes@kbra.com
Ian Jaffe , Managing Director
+1 (646) 731-3302
ian.jaffe@kbra.com
Joe Scott , Senior Managing Director
+1 (646) 731-2438
joe.scott@kbra.com
Business Development Contact
Justin Fuller , Senior Director
+1 (646) 731-1250
justin.fuller@kbra.com
Source: KBRA
Bausch Health Companies Inc
BHC Rankings
#1934 Ranked by Stock Gains
BHC Stock Data
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Tags
Health Technology, Pharmaceuticals: Other, Manufacturing, Pharmaceutical Preparation Manufacturing
Country
CA
City
Laval
About BHC
bausch health companies inc. (nyse/tsx: bhc) is a global company that develops, manufactures and markets a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. we are delivering on our commitments as we build an innovative company dedicated to advancing global health. our approximately 22,000 employees are united around our mission of improving people’s lives with our health care products, and we manufacture and market health care products directly or indirectly in approximately 100 countries.five pillars, or guiding principles, represent the foundation on which we are realizing our mission as an organization: people, quality health care outcomes, customer focus, innovation and efficiency. more information can be found at www.bauschhealth.com.###